12/14/2020 1:07:48 AM
Novocure Announces National Reimbursement In Switzerland For Optune With Temozolomide For Newly Diagnosed Glioblastoma
11/11/2020 7:33:33 AM
Novocure Receives CE Mark For NovoTTF-100L System From The Notified Body
8/13/2020 8:34:48 AM
Novocure Names Wilco Groenhuysen To An Expanded COO Role; Promotes Ashley Cordova To CFO
7/22/2020 7:35:17 AM
Novocure Says First Patient Enrolled In EF-33 Phase 2 Pilot Trial
7/8/2020 7:34:20 AM
Novocure Says About 100 Physicians From More Than 50 Cancer Treatment Centers In U.S. Certified To Prescribe Optune Lua
7/7/2020 7:37:38 AM
Novocure Enrolls Last Patient In HEPANOVA Trial In Advanced Liver Cancer
3/20/2020 9:22:47 AM
Novocure : German Federal Joint Committee Updates Medical Care Directive To Include Tumor Treating Fields
1/9/2020 7:34:16 AM
Zai Lab, Novocure : First Patient Enrolled In Phase 2 Pilot Trial Of Tumor Treating Fields Together With Chemotherapy
7/26/2019 8:36:26 AM
Wedbush Is Cutting NovoCure (NVCR) FY20 Rev. Estimate To 484.6 M From 1601 M
7/26/2019 8:36:01 AM
Wedbush Is Lowering NovoCure (NVCR) Q4 20 Rev. Estimate To 132.8 M From 1163 M
7/26/2019 8:35:49 AM
Wedbush Is Lowering NovoCure (NVCR) Q3 20 Rev. Estimate To 124.8 M From 866.4 M
7/26/2019 8:35:24 AM
Wedbush Is Cutting NovoCure (NVCR) Q2 20 Rev. Estimate To 118.8 M From 609.0 M
7/26/2019 8:35:11 AM
Wedbush Is Lowering NovoCure (NVCR) Q1 20 Rev. Estimate To 108.2 M From 492.1 M
7/26/2019 8:34:51 AM
Wedbush Is Increasing NovoCure (NVCR) FY19 Rev. Estimate To 351.1 M From 348.3 M
7/26/2019 8:34:40 AM
Wedbush Is Cutting NovoCure (NVCR) Q4 19 Rev. Estimate To 99.9 M From 101.0 M
7/26/2019 8:34:29 AM
Wedbush Is Lowering NovoCure (NVCR) Q3 19 Rev. Estimate To 91.2 M From 93.4 M
7/26/2019 8:34:04 AM
Wedbush Is Cutting NovoCure (NVCR) FY20 Estimate To 0.63 From 8.09
7/26/2019 8:33:53 AM
Wedbush Is Lowering NovoCure (NVCR) Q4 20 Estimate To 0.20 From 4.91
7/26/2019 8:33:41 AM
Wedbush Is Lowering NovoCure (NVCR) Q3 20 Estimate To 0.17 From 2.95